ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced Health Canada approval and first implant in Canada of its Prodigy™ Chronic Pain ...
Brian J. Snyder, MD, FAANS, an attending neurosurgeon and partner at Neurological Surgery, P.C. (NSPC) was the first surgeon in New York State to implant the next generation Nevro Senza II Spinal Cord ...
New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain. In a new study, researchers examined opioid ...
Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use and lower explant rates LAKE OSWEGO, Ore., Jan. 5, 2026 /PRNewswire/ -- A new ...
REDWOOD CITY, Calif., May 14, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, ...
Nevro Announces U.S. Launch of Senza® Omnia(TM) Spinal Cord Stimulation System to Treat Chronic Pain
REDWOOD CITY, Calif., Nov. 5, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, today ...
BREDA, Netherlands--(BUSINESS WIRE)--Freedom Neuro BV, a medical device distributor for Stimwave Technologies Incorporated, today announced CE Mark approval for the world’s first Percutaneous ...
How Medtronic spinal cord stimulation therapy helped one woman reclaim her life. For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results